Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 8% in the afternoon session after the U.S. Food and Drug ...
Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...
AlphaQuest LLC cut its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 11.2% during the 4th ...
Citing third-party data, Hettenback said downloads of the Hims & Hers apps increased 47% year over year in February. What it ...
Uttar Pradesh- Hindu Institute of Medical Sciences (HIMS) has reduced the tuition fees of postgraduate (PG program) i.e. MD ...
We recently published a list of 12 Most Shorted Stocks in 2025. In this article, we are going to take a look at where Hims & ...
We recently published a list of 15 Stocks That Outperform the S&P 500 Every Year For the Last 3 Years. In this article, we ...
Telehealth company Hims & Hers (HIMS) saw a major boost in app downloads during February. According to a Top-rated analyst, Craig ...
Hims & Hers generated $1.5 billion in revenue in 2024, reflecting a 69% year-over-year increase. See why I rate HIMS stock a ...
BofA raised the firm’s price target on Hims & Hers to $22 from $21 and keeps an Underperform rating on the shares. February observed sales ...
Hims & Hers Health's revenue grew 69% YoY, boosting its outlook. See why HIMS stock’s growth potential and high implied ...
Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results